Biofilm

Biofilm is a protective shield manufactured by invading organisms to escape attacks from our antibodies and natural killer cells (immune system). Biofilm consists of a polysaccharide extracellular matrix described by microbiologists as a “super glue-like” substance.

Lyme spirochetes, Bartonella, and the mosquito parasite, Protomyxzoa Rheumatica, will wrap themselves in Biofilm if they are not immediately destroyed upon entry into our bloodstream. Thinking in three-dimensional terms, visualize Biofilm “bubbles” floating among red blood cells throughout the bloodstream.

Biofilm causes the “waxing and waning” – or feeling better temporarily after receiving antibiotic therapy – that many chronic Lyme disease patients experiences. These patients feel better temporarily after antibiotics effectively kill spirochetes in the free-floating bloodstream, where many Lyme disease symptoms originate. The problem is that the antibiotic therapy does not kill the spirochetes located inside the Biofilm formations that are floating through the bloodstream.

Several months later, the Biofilm-ridden spirochetes have produced enough offspring to reach a new critical mass effect, and they begin busting through the Biofilm. These spirochetes travel through the free-floating bloodstream, where they attack joints and multiple other organs, most concerning of which is the brain. For this reason, it is important to eradicate Biofilm formations in Lyme disease patients.

While antibiotics can be very effective for killing Lyme Disease spirochetes and other bacteria in the “free-floating” bloodstream, antibiotics do not effectively penetrate the four-layer outer wall of Biofilm formations. However, a small amount of antibiotics do get inside the Biofilm, but just enough to cause antibiotic resistance in Biofilm-protected bacteria.

Validating this concept are recent studies from the Center for Biofilm Engineering at Montana State University (MSU). The center’s research has proven that antibiotics do not effectively penetrate the protective Biofilm produced by Lyme disease spirochetes and other tick-borne microorganisms.

In fact, microbiologists at MSU have stated, “Antibiotic therapy not only fails to produce a bactericidal-kill in Biofilm-protected organisms, but antibiotic therapy given before Biofilm has been adequately dissolved also induces bacterial mutations, creating even more resistant phenotypes.”

According to the American Association of Quantum Medicine (AAQM), the more we use antibiotics to treat Biofilm-producing microorganisms, the stronger and more resistant they become. Furthermore, AAQM suggests Biofilm-producing, drug-resistant microorganisms can only be conquered by enhancing the killing power of the immune system.